Keyphrases
Adverse Effects
33%
Antidepressant Pharmacotherapy
22%
Antidepressants
100%
Anxiety Disorders
100%
Benzodiazepines
100%
Clinical Trials
22%
Co-prescription
11%
Depressive Disorder
100%
Diagnostic Analysis
11%
Dropout
33%
DSM-IV
11%
Escitalopram
22%
Generalized Anxiety Disorder
55%
Later Life
11%
Major Depressive Disorder
55%
Medication Adherence
11%
Medication-related
22%
Older Adults
100%
Older Patients
33%
Open Treatment
11%
Paucity
11%
Placebo
11%
Response Variability
11%
Therapeutic Agents
11%
Treatment Course
11%
Treatment Outcome
100%
Treatment Response
66%
Venlafaxine
22%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
33%
Antidepressant
100%
Benzodiazepine
100%
Clinical Trial
22%
Disease
100%
DSM-IV
11%
Escitalopram
22%
Generalized Anxiety Disorder
55%
Major Depression
55%
Pharmacotherapy
22%
Placebo
11%
Venlafaxine
22%
Neuroscience
Adverse Effect
33%
Antidepressant
100%
Benzodiazepine
100%
Depression
100%
Escitalopram
22%
Generalized Anxiety Disorder
55%
Major Depressive Disorder
55%
Placebo
11%
Venlafaxine
22%
Psychology
Anxiety Disorder
100%
Benzodiazepine
100%
Depression
100%
Generalized Anxiety Disorder
55%